181 related articles for article (PubMed ID: 17855659)
1. Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation.
Goulet B; Sansregret L; Leduy L; Bogyo M; Weber E; Chauhan SS; Nepveu A
Mol Cancer Res; 2007 Sep; 5(9):899-907. PubMed ID: 17855659
[TBL] [Abstract][Full Text] [Related]
2. A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor.
Goulet B; Baruch A; Moon NS; Poirier M; Sansregret LL; Erickson A; Bogyo M; Nepveu A
Mol Cell; 2004 Apr; 14(2):207-19. PubMed ID: 15099520
[TBL] [Abstract][Full Text] [Related]
3. A novel proteolytically processed CDP/Cux isoform of 90 kDa is generated by cathepsin L.
Goulet B; Truscott M; Nepveu A
Biol Chem; 2006 Sep; 387(9):1285-93. PubMed ID: 16972798
[TBL] [Abstract][Full Text] [Related]
4. [Cathepsins L and B and their endogenous inhibitors in embryonal fibroblasts transformed by different genes].
Dilakian EA; Vinokurova SV; Zhurbitskaia VA; Komissarova EV; Topol' LZ; Kiselev FL; Solov'eva NI
Vopr Med Khim; 1998; 44(1):35-42. PubMed ID: 9575611
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of CDP/Cux p110 by cyclin A/Cdk2 and cyclin A/Cdk1.
Santaguida M; Nepveu A
J Biol Chem; 2005 Sep; 280(38):32712-21. PubMed ID: 16081423
[TBL] [Abstract][Full Text] [Related]
6. Nuclear localization of procathepsin L/MEP in ras-transformed mouse fibroblasts.
Hiwasa T; Sakiyama S
Cancer Lett; 1996 Jan; 99(1):87-91. PubMed ID: 8564934
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a tissue-specific CDP/Cux isoform, p75, activated in breast tumor cells.
Goulet B; Watson P; Poirier M; Leduy L; Bérubé G; Meterissian S; Jolicoeur P; Nepveu A
Cancer Res; 2002 Nov; 62(22):6625-33. PubMed ID: 12438259
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic enzymes at various stages of oncogenic transformation of rat fibroblasts. I. Aspartyl and cysteine proteinases.
Solovyeva NI; Balayevskaya TO; Dilakyan EA; Zakamaldina-Zama TA; Pozdnev VF; Topol LZ; Kisseljov FL
Int J Cancer; 1995 Feb; 60(4):495-500. PubMed ID: 7829263
[TBL] [Abstract][Full Text] [Related]
9. Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues.
Dodds RA; Connor JR; Drake FH; Gowen M
Arthritis Rheum; 1999 Aug; 42(8):1588-93. PubMed ID: 10446855
[TBL] [Abstract][Full Text] [Related]
10. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
Tournu C; Obled A; Roux MP; Deval C; Ferrara M; Béchet DM
Arch Biochem Biophys; 1998 Dec; 360(1):15-24. PubMed ID: 9826424
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin L splice variants in human breast cell lines.
Caserman S; Kenig S; Sloane BF; Lah TT
Biol Chem; 2006 May; 387(5):629-34. PubMed ID: 16740135
[TBL] [Abstract][Full Text] [Related]
12. Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1.
Alcalay NI; Sharma M; Vassmer D; Chapman B; Paul B; Zhou J; Brantley JG; Wallace DP; Maser RL; Vanden Heuvel GB
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1725-34. PubMed ID: 18829740
[TBL] [Abstract][Full Text] [Related]
13. The p110 isoform of the CDP/Cux transcription factor accelerates entry into S phase.
Sansregret L; Goulet B; Harada R; Wilson B; Leduy L; Bertoglio J; Nepveu A
Mol Cell Biol; 2006 Mar; 26(6):2441-55. PubMed ID: 16508018
[TBL] [Abstract][Full Text] [Related]
14. Analysis of proteins with caseinolytic activity in a human stratum corneum extract revealed a yet unidentified cysteine protease and identified the so-called "stratum corneum thiol protease" as cathepsin l2.
Bernard D; Méhul B; Thomas-Collignon A; Simonetti L; Remy V; Bernard MA; Schmidt R
J Invest Dermatol; 2003 Apr; 120(4):592-600. PubMed ID: 12648222
[TBL] [Abstract][Full Text] [Related]
15. Expression of cathepsin L in human tumor cells is under the control of distinct regulatory mechanisms.
Jean D; Rousselet N; Frade R
Oncogene; 2006 Mar; 25(10):1474-84. PubMed ID: 16261157
[TBL] [Abstract][Full Text] [Related]
16. Involvement of carboxy-terminal amino acids in secretion of human lysosomal protease cathepsin L.
Chauhan SS; Ray D; Kane SE; Willingham MC; Gottesman MM
Biochemistry; 1998 Jun; 37(23):8584-94. PubMed ID: 9622510
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cathepsin L synthesized by normal and transformed cells at the gene, message, protein, and oligosaccharide levels.
Stearns NA; Dong JM; Pan JX; Brenner DA; Sahagian GG
Arch Biochem Biophys; 1990 Dec; 283(2):447-57. PubMed ID: 2275556
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells.
Liu J; Sukhova GK; Yang JT; Sun J; Ma L; Ren A; Xu WH; Fu H; Dolganov GM; Hu C; Libby P; Shi GP
Atherosclerosis; 2006 Feb; 184(2):302-11. PubMed ID: 15982660
[TBL] [Abstract][Full Text] [Related]
19. Multiple processing of procathepsin L to cathepsin L in vivo.
Ishidoh K; Saido TC; Kawashima S; Hirose M; Watanabe S; Sato N; Kominami E
Biochem Biophys Res Commun; 1998 Nov; 252(1):202-7. PubMed ID: 9813170
[TBL] [Abstract][Full Text] [Related]
20. Significance of nuclear cathepsin V in normal thyroid epithelial and carcinoma cells.
Al-Hashimi A; Venugopalan V; Sereesongsaeng N; Tedelind S; Pinzaru AM; Hein Z; Springer S; Weber E; Führer D; Scott CJ; Burden RE; Brix K
Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118846. PubMed ID: 32910988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
